UniProt ID | HNRPL_HUMAN | |
---|---|---|
UniProt AC | P14866 | |
Protein Name | Heterogeneous nuclear ribonucleoprotein L | |
Gene Name | HNRNPL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 589 | |
Subcellular Localization | Nucleus, nucleoplasm . Cytoplasm . Localized in cytoplasmic mRNP granules containing untranslated mRNAs. These granules are not identical with P bodies or stress granules. | |
Protein Description | Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion. Exhibits a binding preference for CA-rich elements. [PubMed: 11809897] | |
Protein Sequence | MSRRLLPRAEKRRRRLEQRQQPDEQRRRSGAMVKMAAAGGGGGGGRYYGGGSEGGRAPKRLKTDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHKTPASPVVHIRGLIDGVVEADLVEALQEFGPISYVVVMPKKRQALVEFEDVLGACNAVNYAADNQIYIAGHPAFVNYSTSQKISRPGDSDDSRSVNSVLLFTILNPIYSITTDVLYTICNPCGPVQRIVIFRKNGVQAMVEFDSVQSAQRAKASLNGADIYSGCCTLKIEYAKPTRLNVFKNDQDTWDYTNPNLSGQGDPGSNPNKRQRQPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGRRMGPPVGGHRRGPSRYGPQYGHPPPPPPPPEYGPHADSPVLMVYGLDQSKMNCDRVFNVFCLYGNVEKVKFMKSKPGAAMVEMADGYAVDRAITHLNNNFMFGQKLNVCVSKQPAIMPGQSYGLEDGSCSYKDFSESRNNRFSTPEQAAKNRIQHPSNVLHFFNAPLEVTEENFFEICDELGVKRPSSVKVFSGKSERSSSGLLEWESKSDALETLGFLNHYQMKNPNGPYPYTLKLCFSTAQHAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRRLLPRA ------CCCCHHHHH | 26.55 | 26074081 | |
29 | Phosphorylation | PDEQRRRSGAMVKMA CHHHHHHHHCEEEEH | 29.14 | 28985074 | |
34 | Acetylation | RRSGAMVKMAAAGGG HHHHCEEEEHHCCCC | 15.10 | 25953088 | |
34 | Ubiquitination | RRSGAMVKMAAAGGG HHHHCEEEEHHCCCC | 15.10 | - | |
46 | Methylation | GGGGGGGRYYGGGSE CCCCCCCCCCCCCCC | 25.44 | 30759965 | |
47 | Phosphorylation | GGGGGGRYYGGGSEG CCCCCCCCCCCCCCC | 15.10 | 21945579 | |
48 | Phosphorylation | GGGGGRYYGGGSEGG CCCCCCCCCCCCCCC | 14.13 | 21945579 | |
52 | Phosphorylation | GRYYGGGSEGGRAPK CCCCCCCCCCCCCCC | 36.02 | 25159151 | |
56 | Methylation | GGGSEGGRAPKRLKT CCCCCCCCCCCCCCC | 59.58 | 115479267 | |
59 | Sumoylation | SEGGRAPKRLKTDNA CCCCCCCCCCCCCCC | 70.18 | - | |
59 | Acetylation | SEGGRAPKRLKTDNA CCCCCCCCCCCCCCC | 70.18 | 25953088 | |
59 | Sumoylation | SEGGRAPKRLKTDNA CCCCCCCCCCCCCCC | 70.18 | 28112733 | |
59 | Ubiquitination | SEGGRAPKRLKTDNA CCCCCCCCCCCCCCC | 70.18 | - | |
62 | Sumoylation | GRAPKRLKTDNAGDQ CCCCCCCCCCCCCCC | 58.84 | - | |
62 | Acetylation | GRAPKRLKTDNAGDQ CCCCCCCCCCCCCCC | 58.84 | 26051181 | |
62 | Sumoylation | GRAPKRLKTDNAGDQ CCCCCCCCCCCCCCC | 58.84 | 28112733 | |
62 | Ubiquitination | GRAPKRLKTDNAGDQ CCCCCCCCCCCCCCC | 58.84 | 21890473 | |
63 | Phosphorylation | RAPKRLKTDNAGDQH CCCCCCCCCCCCCCC | 38.79 | 21945579 | |
92 | Phosphorylation | GGGGGENYDDPHKTP CCCCCCCCCCCCCCC | 19.88 | 21945579 | |
97 | Acetylation | ENYDDPHKTPASPVV CCCCCCCCCCCCCEE | 62.69 | 25953088 | |
97 | Ubiquitination | ENYDDPHKTPASPVV CCCCCCCCCCCCCEE | 62.69 | 21890473 | |
98 | Phosphorylation | NYDDPHKTPASPVVH CCCCCCCCCCCCEEE | 22.51 | 21945579 | |
101 | Phosphorylation | DPHKTPASPVVHIRG CCCCCCCCCEEEHHH | 21.30 | 21945579 | |
107 | Methylation | ASPVVHIRGLIDGVV CCCEEEHHHHCCCCC | 20.98 | 115384333 | |
136 | Ubiquitination | SYVVVMPKKRQALVE EEEEEECCCCCEEEE | 42.36 | 21890473 | |
136 | Sumoylation | SYVVVMPKKRQALVE EEEEEECCCCCEEEE | 42.36 | - | |
136 | Acetylation | SYVVVMPKKRQALVE EEEEEECCCCCEEEE | 42.36 | 19608861 | |
136 | Sumoylation | SYVVVMPKKRQALVE EEEEEECCCCCEEEE | 42.36 | 28112733 | |
136 | Ubiquitination | SYVVVMPKKRQALVE EEEEEECCCCCEEEE | 42.36 | 19608861 | |
144 | Ubiquitination | KRQALVEFEDVLGAC CCCEEEEHHHHHHHH | 8.29 | 21890473 | |
169 | Ubiquitination | IYIAGHPAFVNYSTS EEECCCCCEECCCCC | 18.49 | 21890473 | |
180 | Phosphorylation | YSTSQKISRPGDSDD CCCCCCCCCCCCCCC | 39.18 | 30266825 | |
185 | Phosphorylation | KISRPGDSDDSRSVN CCCCCCCCCCCCCCH | 49.59 | 29255136 | |
188 | Phosphorylation | RPGDSDDSRSVNSVL CCCCCCCCCCCHHHH | 31.29 | 30266825 | |
229 | Ubiquitination | QRIVIFRKNGVQAMV EEEEEEECCCEEEEE | 47.51 | 21906983 | |
248 | 2-Hydroxyisobutyrylation | VQSAQRAKASLNGAD HHHHHHHHHHHCCCH | 40.47 | - | |
248 | Malonylation | VQSAQRAKASLNGAD HHHHHHHHHHHCCCH | 40.47 | 26320211 | |
248 | Ubiquitination | VQSAQRAKASLNGAD HHHHHHHHHHHCCCH | 40.47 | - | |
250 | Phosphorylation | SAQRAKASLNGADIY HHHHHHHHHCCCHHH | 22.97 | 21712546 | |
257 | Phosphorylation | SLNGADIYSGCCTLK HHCCCHHHCCCCEEE | 10.27 | 28152594 | |
258 | Phosphorylation | LNGADIYSGCCTLKI HCCCHHHCCCCEEEE | 26.20 | 28152594 | |
260 | S-nitrosocysteine | GADIYSGCCTLKIEY CCHHHCCCCEEEEEE | 1.00 | - | |
260 | S-nitrosylation | GADIYSGCCTLKIEY CCHHHCCCCEEEEEE | 1.00 | 19483679 | |
261 | S-nitrosocysteine | ADIYSGCCTLKIEYA CHHHCCCCEEEEEEC | 5.95 | - | |
261 | S-nitrosylation | ADIYSGCCTLKIEYA CHHHCCCCEEEEEEC | 5.95 | 19483679 | |
262 | Phosphorylation | DIYSGCCTLKIEYAK HHHCCCCEEEEEECC | 34.85 | 28152594 | |
264 | Acetylation | YSGCCTLKIEYAKPT HCCCCEEEEEECCCC | 18.48 | 23749302 | |
264 | Ubiquitination | YSGCCTLKIEYAKPT HCCCCEEEEEECCCC | 18.48 | - | |
267 | Phosphorylation | CCTLKIEYAKPTRLN CCEEEEEECCCCEEE | 24.33 | 28152594 | |
269 | Acetylation | TLKIEYAKPTRLNVF EEEEEECCCCEEEEE | 46.12 | 19608861 | |
269 | Ubiquitination | TLKIEYAKPTRLNVF EEEEEECCCCEEEEE | 46.12 | 21890473 | |
271 | Phosphorylation | KIEYAKPTRLNVFKN EEEECCCCEEEEEEC | 47.27 | 28152594 | |
277 | Acetylation | PTRLNVFKNDQDTWD CCEEEEEECCCCCCC | 56.16 | 26051181 | |
277 | Sumoylation | PTRLNVFKNDQDTWD CCEEEEEECCCCCCC | 56.16 | - | |
277 | Ubiquitination | PTRLNVFKNDQDTWD CCEEEEEECCCCCCC | 56.16 | 21890473 | |
282 | Phosphorylation | VFKNDQDTWDYTNPN EEECCCCCCCCCCCC | 18.01 | 28796482 | |
285 | Phosphorylation | NDQDTWDYTNPNLSG CCCCCCCCCCCCCCC | 10.44 | 28796482 | |
286 | Phosphorylation | DQDTWDYTNPNLSGQ CCCCCCCCCCCCCCC | 41.55 | 23663014 | |
291 | Phosphorylation | DYTNPNLSGQGDPGS CCCCCCCCCCCCCCC | 35.39 | 25159151 | |
298 | Phosphorylation | SGQGDPGSNPNKRQR CCCCCCCCCCCCCCC | 55.27 | 25159151 | |
302 | Sumoylation | DPGSNPNKRQRQPPL CCCCCCCCCCCCCCC | 51.68 | - | |
302 | Acetylation | DPGSNPNKRQRQPPL CCCCCCCCCCCCCCC | 51.68 | 25953088 | |
302 | Sumoylation | DPGSNPNKRQRQPPL CCCCCCCCCCCCCCC | 51.68 | 28112733 | |
302 | Ubiquitination | DPGSNPNKRQRQPPL CCCCCCCCCCCCCCC | 51.68 | 21890473 | |
328 | Phosphorylation | HGGYHSHYHDEGYGP CCCCCCCCCCCCCCC | 17.62 | - | |
333 | Phosphorylation | SHYHDEGYGPPPPHY CCCCCCCCCCCCCCC | 25.14 | 20736484 | |
340 | Phosphorylation | YGPPPPHYEGRRMGP CCCCCCCCCCCCCCC | 26.33 | - | |
342 | Acetylation | PPPPHYEGRRMGPPV CCCCCCCCCCCCCCC | 18.48 | 19608861 | |
344 | Methylation | PPHYEGRRMGPPVGG CCCCCCCCCCCCCCC | 45.31 | 81449371 | |
354 | Asymmetric dimethylarginine | PPVGGHRRGPSRYGP CCCCCCCCCCCCCCC | 56.55 | - | |
354 | Methylation | PPVGGHRRGPSRYGP CCCCCCCCCCCCCCC | 56.55 | 54548201 | |
358 | Asymmetric dimethylarginine | GHRRGPSRYGPQYGH CCCCCCCCCCCCCCC | 43.49 | - | |
358 | Methylation | GHRRGPSRYGPQYGH CCCCCCCCCCCCCCC | 43.49 | 54548207 | |
359 | Phosphorylation | HRRGPSRYGPQYGHP CCCCCCCCCCCCCCC | 37.18 | 21945579 | |
363 | Phosphorylation | PSRYGPQYGHPPPPP CCCCCCCCCCCCCCC | 22.12 | 21945579 | |
375 | Phosphorylation | PPPPPPEYGPHADSP CCCCCCCCCCCCCCC | 41.55 | 21945579 | |
381 | Phosphorylation | EYGPHADSPVLMVYG CCCCCCCCCEEEEEE | 20.07 | 21945579 | |
387 | Phosphorylation | DSPVLMVYGLDQSKM CCCEEEEEECCHHHC | 9.67 | 21945579 | |
392 | Phosphorylation | MVYGLDQSKMNCDRV EEEECCHHHCCHHHH | 33.27 | 21945579 | |
393 | 2-Hydroxyisobutyrylation | VYGLDQSKMNCDRVF EEECCHHHCCHHHHE | 28.62 | - | |
393 | Acetylation | VYGLDQSKMNCDRVF EEECCHHHCCHHHHE | 28.62 | 26051181 | |
398 | Methylation | QSKMNCDRVFNVFCL HHHCCHHHHEEEEEE | 36.81 | 115479235 | |
400 | Ubiquitination | KMNCDRVFNVFCLYG HCCHHHHEEEEEEEC | 7.22 | 21890473 | |
404 | Glutathionylation | DRVFNVFCLYGNVEK HHHEEEEEEECCEEE | 2.20 | 22555962 | |
406 | Phosphorylation | VFNVFCLYGNVEKVK HEEEEEEECCEEEEE | 14.08 | 28152594 | |
411 | Acetylation | CLYGNVEKVKFMKSK EEECCEEEEEEECCC | 46.58 | 25953088 | |
411 | Ubiquitination | CLYGNVEKVKFMKSK EEECCEEEEEEECCC | 46.58 | 21906983 | |
413 | Ubiquitination | YGNVEKVKFMKSKPG ECCEEEEEEECCCCC | 51.30 | - | |
416 | Acetylation | VEKVKFMKSKPGAAM EEEEEEECCCCCCEE | 59.46 | 25953088 | |
416 | Ubiquitination | VEKVKFMKSKPGAAM EEEEEEECCCCCCEE | 59.46 | - | |
417 | Phosphorylation | EKVKFMKSKPGAAMV EEEEEECCCCCCEEE | 32.09 | 21406692 | |
418 | Sumoylation | KVKFMKSKPGAAMVE EEEEECCCCCCEEEE | 41.79 | - | |
418 | 2-Hydroxyisobutyrylation | KVKFMKSKPGAAMVE EEEEECCCCCCEEEE | 41.79 | - | |
418 | Acetylation | KVKFMKSKPGAAMVE EEEEECCCCCCEEEE | 41.79 | 26051181 | |
418 | Malonylation | KVKFMKSKPGAAMVE EEEEECCCCCCEEEE | 41.79 | 26320211 | |
418 | Sumoylation | KVKFMKSKPGAAMVE EEEEECCCCCCEEEE | 41.79 | - | |
418 | Ubiquitination | KVKFMKSKPGAAMVE EEEEECCCCCCEEEE | 41.79 | - | |
419 | Acetylation | VKFMKSKPGAAMVEM EEEECCCCCCEEEEE | 44.75 | 19608861 | |
423 | Sulfoxidation | KSKPGAAMVEMADGY CCCCCCEEEEECCCC | 2.32 | 28183972 | |
426 | Sulfoxidation | PGAAMVEMADGYAVD CCCEEEEECCCCHHH | 2.54 | 28183972 | |
430 | Phosphorylation | MVEMADGYAVDRAIT EEEECCCCHHHHHHH | 12.19 | 21406692 | |
434 | Methylation | ADGYAVDRAITHLNN CCCCHHHHHHHHCCC | 22.69 | 115479259 | |
435 | Ubiquitination | DGYAVDRAITHLNNN CCCHHHHHHHHCCCC | 13.43 | 21890473 | |
437 | Phosphorylation | YAVDRAITHLNNNFM CHHHHHHHHCCCCCC | 21.23 | 20068231 | |
448 | Acetylation | NNFMFGQKLNVCVSK CCCCCCCEEEEEEEC | 42.27 | 23749302 | |
452 | S-nitrosocysteine | FGQKLNVCVSKQPAI CCCEEEEEEECCCCC | 2.52 | - | |
452 | Glutathionylation | FGQKLNVCVSKQPAI CCCEEEEEEECCCCC | 2.52 | 22555962 | |
452 | S-nitrosylation | FGQKLNVCVSKQPAI CCCEEEEEEECCCCC | 2.52 | 19483679 | |
455 | Acetylation | KLNVCVSKQPAIMPG EEEEEEECCCCCCCC | 39.65 | 25953088 | |
455 | Malonylation | KLNVCVSKQPAIMPG EEEEEEECCCCCCCC | 39.65 | 26320211 | |
455 | Ubiquitination | KLNVCVSKQPAIMPG EEEEEEECCCCCCCC | 39.65 | - | |
464 | Phosphorylation | PAIMPGQSYGLEDGS CCCCCCCCCCCCCCC | 27.38 | 21406692 | |
465 | Phosphorylation | AIMPGQSYGLEDGSC CCCCCCCCCCCCCCC | 20.17 | 21406692 | |
471 | Phosphorylation | SYGLEDGSCSYKDFS CCCCCCCCCCCCCCC | 16.53 | 21406692 | |
473 | Phosphorylation | GLEDGSCSYKDFSES CCCCCCCCCCCCCHH | 36.59 | 21406692 | |
474 | Phosphorylation | LEDGSCSYKDFSESR CCCCCCCCCCCCHHH | 20.92 | 21406692 | |
475 | Acetylation | EDGSCSYKDFSESRN CCCCCCCCCCCHHHC | 35.68 | 23954790 | |
475 | Ubiquitination | EDGSCSYKDFSESRN CCCCCCCCCCCHHHC | 35.68 | 19608861 | |
478 | Phosphorylation | SCSYKDFSESRNNRF CCCCCCCCHHHCCCC | 44.81 | 21406692 | |
480 | Phosphorylation | SYKDFSESRNNRFST CCCCCCHHHCCCCCC | 38.83 | 21406692 | |
486 | Phosphorylation | ESRNNRFSTPEQAAK HHHCCCCCCHHHHHH | 39.55 | 20068231 | |
487 | Phosphorylation | SRNNRFSTPEQAAKN HHCCCCCCHHHHHHH | 28.29 | 25159151 | |
493 | Acetylation | STPEQAAKNRIQHPS CCHHHHHHHHCCCCH | 50.18 | 25953088 | |
493 | Ubiquitination | STPEQAAKNRIQHPS CCHHHHHHHHCCCCH | 50.18 | - | |
527 | Ubiquitination | ICDELGVKRPSSVKV HHHHHCCCCCCCEEE | 57.71 | 21906983 | |
530 | Phosphorylation | ELGVKRPSSVKVFSG HHCCCCCCCEEEECC | 52.36 | 28176443 | |
531 | Phosphorylation | LGVKRPSSVKVFSGK HCCCCCCCEEEECCC | 28.74 | 24719451 | |
533 | 2-Hydroxyisobutyrylation | VKRPSSVKVFSGKSE CCCCCCEEEECCCCC | 39.24 | - | |
533 | Acetylation | VKRPSSVKVFSGKSE CCCCCCEEEECCCCC | 39.24 | 25953088 | |
533 | Ubiquitination | VKRPSSVKVFSGKSE CCCCCCEEEECCCCC | 39.24 | 21890473 | |
536 | Phosphorylation | PSSVKVFSGKSERSS CCCEEEECCCCCCCC | 48.58 | 23312004 | |
538 | Sumoylation | SVKVFSGKSERSSSG CEEEECCCCCCCCCC | 48.20 | - | |
538 | 2-Hydroxyisobutyrylation | SVKVFSGKSERSSSG CEEEECCCCCCCCCC | 48.20 | - | |
538 | Acetylation | SVKVFSGKSERSSSG CEEEECCCCCCCCCC | 48.20 | 26051181 | |
538 | Succinylation | SVKVFSGKSERSSSG CEEEECCCCCCCCCC | 48.20 | 23954790 | |
538 | Sumoylation | SVKVFSGKSERSSSG CEEEECCCCCCCCCC | 48.20 | - | |
538 | Ubiquitination | SVKVFSGKSERSSSG CEEEECCCCCCCCCC | 48.20 | - | |
539 | Phosphorylation | VKVFSGKSERSSSGL EEEECCCCCCCCCCC | 41.59 | 26714015 | |
542 | Phosphorylation | FSGKSERSSSGLLEW ECCCCCCCCCCCEEE | 25.46 | 28450419 | |
543 | Phosphorylation | SGKSERSSSGLLEWE CCCCCCCCCCCEEEE | 34.35 | 28450419 | |
544 | Phosphorylation | GKSERSSSGLLEWES CCCCCCCCCCEEEEE | 34.41 | 25218447 | |
552 | Acetylation | GLLEWESKSDALETL CCEEEEEHHHHHHHH | 40.62 | 23954790 | |
552 | Sumoylation | GLLEWESKSDALETL CCEEEEEHHHHHHHH | 40.62 | 19608861 | |
552 | Ubiquitination | GLLEWESKSDALETL CCEEEEEHHHHHHHH | 40.62 | 19608861 | |
553 | Phosphorylation | LLEWESKSDALETLG CEEEEEHHHHHHHHH | 37.08 | 20873877 | |
565 | Phosphorylation | TLGFLNHYQMKNPNG HHHHCHHCCCCCCCC | 14.83 | - | |
568 | Acetylation | FLNHYQMKNPNGPYP HCHHCCCCCCCCCCC | 54.44 | 25953088 | |
568 | Sumoylation | FLNHYQMKNPNGPYP HCHHCCCCCCCCCCC | 54.44 | 28112733 | |
568 | Ubiquitination | FLNHYQMKNPNGPYP HCHHCCCCCCCCCCC | 54.44 | 21890473 | |
574 | Phosphorylation | MKNPNGPYPYTLKLC CCCCCCCCCEEEEEE | 15.40 | 20090780 | |
576 | Phosphorylation | NPNGPYPYTLKLCFS CCCCCCCEEEEEEEC | 20.89 | 20090780 | |
577 | Phosphorylation | PNGPYPYTLKLCFST CCCCCCEEEEEEECC | 16.95 | 28152594 | |
579 | Acetylation | GPYPYTLKLCFSTAQ CCCCEEEEEEECCCC | 35.10 | 25953088 | |
579 | Ubiquitination | GPYPYTLKLCFSTAQ CCCCEEEEEEECCCC | 35.10 | - | |
581 | S-nitrosocysteine | YPYTLKLCFSTAQHA CCEEEEEEECCCCCC | 2.12 | - | |
581 | Glutathionylation | YPYTLKLCFSTAQHA CCEEEEEEECCCCCC | 2.12 | 22555962 | |
581 | S-nitrosylation | YPYTLKLCFSTAQHA CCEEEEEEECCCCCC | 2.12 | 22178444 | |
583 | Phosphorylation | YTLKLCFSTAQHAS- EEEEEEECCCCCCC- | 23.10 | 23403867 | |
584 | Phosphorylation | TLKLCFSTAQHAS-- EEEEEECCCCCCC-- | 15.30 | 23403867 | |
589 | Phosphorylation | FSTAQHAS------- ECCCCCCC------- | 38.33 | 23401153 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
544 | S | Phosphorylation | Kinase | CAMK4 | Q16566 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
544 | S | Phosphorylation |
| 22570490 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HNRPL_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-269; LYS-475 AND LYS-552,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52 AND SER-298, AND MASSSPECTROMETRY. |